Who
Tony Serge Lialin
Chief Commercial Officer
Company insider
Files Form 4 as: Chief Commercial Officer, VivoSim Labs.
In numbers
- Trades disclosed
- 3
- Buys
- 1
- Sells
- 0
- Bought
- $5,604
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 11 Aug 2025
- Last trade
- 31 Aug 2026
- Last filed
- 1 Sep 2026
Companies traded
Activity over time
1 Aug – 1 Oct
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 31 Aug 2026filed 1 Sep 2026 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Bought | $2,80410,000 at $0.2804 | filing |
| 31 Aug 2026filed 1 Sep 2026 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Bought | $2,80010,000 at $0.28 | filing |
| 11 Aug 2025filed 21 Aug 2025 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —40,000 at $0.00 | filing |
News
Charles River Laboratories International (NYSE:CRL) versus VivoSim Labs (NASDAQ:VIVS) Head-To-Head ContrastVIVS · dailypolitical.com · 22 Oct 2026VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker ProfilingVIVS · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name Tony Serge Lialin; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.